Myocardial perfusion is preserved in patients with psoriasis without clinically evident cardiovascular disease

Journal of the European Academy of Dermatology and Venereology

Volumn 23, Issue 7, 2009, Pages 798-802

  Yalcin, H ^a   Balci, D D ^b   Ucar, E ^b   Ozcelik, N ^c   Tasci, C ^c   Seyfeli, E ^b   Akgul, F ^b   Yalcin, F ^b  

^a MUSTAFA KEMAL UNIVERSITY   (Turkey)

^b Department of Dermatology ^*  (Turkey)

^c Gamma Nuclear Imaging Center   (Turkey)

Author keywords

99mTc MIBI SPECT; Coronary artery disease; Myocardial perfusion; Psoriasis

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CORONARY ARTERY OBSTRUCTION; DISEASE DURATION; FAMILY HISTORY; FEMALE; HEART INFARCTION; HEART MUSCLE PERFUSION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INFLAMMATION; MALE; PRIORITY JOURNAL; PSORIASIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SMOKING;

ADOLESCENT; ADULT; AGED; CARDIOVASCULAR DISEASES; CORONARY CIRCULATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PSORIASIS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; YOUNG ADULT;

EID: 66749146014     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2009.03178.x     Document Type: Article

References (38)

1. De Korte J, Sprangers MAG, Mombers FMC, Bos JD. Quality of life in patients with psoriasis: a systematic literature review. J Investig Dermatol Symp Proc 2004 9 : 140 147. (Pubitemid 38457272)
2. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005 352 : 1685 1695.
3. Kremers HM, McEvoy MT, Dann FJ, Gabriel SE. Heart disease in psoriasis. J Am Acad Dermatol 2007 57 : 347 354. (Pubitemid 47048862)
4. Krueger JG. The immunologic basis for the treatment of psoriasis with new biologic agents. J Am Acad Dermatol 2002 46 : 1 23. (Pubitemid 34073472)
5. Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB, Gelfand JM. Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol 2006 55 : 829 835. (Pubitemid 44556851)
6. McDonald CJ, Calabresi P. Psoriasis and occlusive vascular disease. Br J Dermatol 1978 99 : 469 475. (Pubitemid 9048948)
7. Bianco JA, Wilson MA. Myocardial ischemia and viability. In : Wilson MA, ed. Textbook of Nuclear Medicine, 1st edn. Lippincott-Raven, Philadelphia, 1998 : 33 56.
8. Ridker PM. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 2001 103 : 1813 1818. (Pubitemid 32291421)
9. Mallbris L, Pernow J, Stahle M. Endothelial function and inflammatory activity in patients with recent onset of severe plaque psoriasis. Open Dermatol J 2008 2 : 64 68.
10. Balci D, Balci A, Karazincir S et al. Increased carotid artery intima-media thickness and impaired endothelial function in psoriasis. J Eur Acad Dermatol Venereol 2009 23 : 1 6.
11. Mallbris L, Akre O, Granath F et al. Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients. Eur J Epidemiol 2004 19 : 225 230. (Pubitemid 38461682)
12. Ludwig RJ, Herzog C, Rostock A et al. Psoriasis: a possible risk factor for development of coronary artery calcification. Br J Dermatol 2007 156 : 271 276. (Pubitemid 46095954)
13. Poikolainen K, Karvonen J, Pukkala E. Excess mortality related to alcohol and smoking among hospital treated patients with psoriasis. Arch Dermatol 1999 135 : 1490 1493.
14. Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB. Risk of myocardial infarction in patients with psoriasis. JAMA 2006 296 : 1735 1741. (Pubitemid 44547793)
15. Shapiro J, Cohen AD, David M et al. The association between psoriasis, diabetes mellitus, and atherosclerosis in Israel: a case-control study. J Am Acad Dermatol 2007 56 : 629 634. (Pubitemid 46400186)
16. Maradit-Kremers H, Crowson CS, Nicola PJ et al. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum 2005 52 : 402 411. (Pubitemid 40220344)
17. Roman MJ, Shanker BA, Davis A et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med 2003 349 : 2399 2406. (Pubitemid 37542988)
18. Hansson GK, Libby P. The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol 2006 6 : 508 519. (Pubitemid 43980523)
19. Gudjonsson JE, Johnston A, Sigmundsdottir H, Valdimarsson H. Immunopathogenic mechanisms in psoriasis. Clin Exp Immunol 2004 135 : 1 8. (Pubitemid 38067920)
20. Schon MP, Boehncke WH. Psoriasis. N Engl J Med 2005 352 : 1899 1912. (Pubitemid 40627816)
21. Trevisan G, Stinco G, Giansante C, Fiotti N, Vidimari P, Kokelj F. Psoriasis and endothelins. Acta Derm Venereol Suppl(Stockh) 1994 186 : 139 140. (Pubitemid 24208183)
22. Creamer D, Sullivan D, Bicknell R, Barker J. Angiogenesis in psoriasis. Angiogenesis 2002 5 : 231 236. (Pubitemid 36875122)
23. Kimball AB, Robinson D Jr., Wu Y et al. Cardiovascular disease and risk factors among psoriasis patients in two US healthcare databases, 2001-02. Dermatology 2008 217 : 27 37.
24. Maxwell SR, Moots RJ, Kendall MJ. Corticosteroids: do they damage the cardiovascular system? Postgrad Med J 1994 70 : 863 870.
25. Landewé RB, van den Borne BE, Breedveld FC, Dijkmans BA. Methotrexate effects in patients with rheumatoid arthritis with cardiovascular comorbidity. Lancet 2000 355 : 1616 1617. (Pubitemid 30240511)
26. Krämer BK, Böger C, Krüger B et al. Cardiovascular risk estimates and risk factors in renal transplant recipients. Transplant Proc 2005 37 : 1868 1870. (Pubitemid 40790853)
27. Taler SJ, Textor SC, Canzanello VJ, Schwartz L. Cyclosporin-induced hypertension: incidence, pathogenesis and management. Drug Saf 1999 20 : 437 449. (Pubitemid 29231658)
28. Katz HI, Waalen J, Leach EE. Acitretin in psoriasis: an overview of adverse effects. J Am Acad Dermatol (Suppl) 1999 41 : 7 12.
29. Gupta AK, Goldfarb MT, Ellis CN, Voorhees JJ. Side-effect profile of acitretin therapy in psoriasis. J Am Acad Dermatol 1989 20 : 1088 1093. (Pubitemid 19151521)
30. Raychaudhuri SP, Gross J. Psoriasis risk factors: role of lifestyle practices. Cutis 2000 66 : 348 352.
31. Herron MD, Hinckley M, Hoffman MS, Papenfuss J, Hansen CB, Callis KP. Impact of obesity and smoking on psoriasis presentation and management. Arch Dermatol 2005 141 : 1527 1534. (Pubitemid 41815842)
32. Mallbris L, Granath F, Hamsten A, Stahle M. Psoriasis is associated with lipid abnormalities at the onset of skin disease. J Am Acad Dermatol 2006 54 : 614 621.
33. Arad Y, Goodman KJ, Roth M. Coronary calcification, coronary disease risk factors, C-reactive protein, and atherosclerotic cardiovascular disease events: the St Francis Heart Study. J Am Coll Cardiol 2005 46 : 158 165. (Pubitemid 40905145)
34. Leonardi CL, Powers JL, Matheson RT et al. Etanercept as monotherapy in patients with psoriasis. N Engl J Med 2003 349 : 2014 2022. (Pubitemid 37448924)
35. Gonzalez-Juanatey C, Llorca J, Miranda-Filloy JA et al. Endothelial dysfunction in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors. Arthritis Rheum 2007 57 : 287 293. (Pubitemid 47164092)
36. Gonzalez-Juanatey C, Llorca J, Amigo-Diaz E, Dierssen T, Martin J, Gonzalez-Gay MA. High prevalence of subclinical atherosclerosis in psoriatic arthritis without clinically evident cardiovascular disease or classic atherosclerosis risk factors. Arthritis Rheum 2007 57 : 1074 1080. (Pubitemid 47237336)
37. Gonzalez-Juanatey C, Amigo-Diaz E, Miranda-Filloy JA et al. Lack of echocardiographic and Doppler abnormalities in psoriatic arthritis without clinically evident cardiovascular disease or classic atherosclerosis risk factors. Semin Arthritis Rheum 2006 35 : 333 339.
38. Yamagishi M, Terashima M, Awano K et al. Morphology of vulnerable coronary plaque: insights from follow-up of patients examined by intravascular ultrasound before an acute coronary syndrome. J Am Coll Cardiol 2000 35 : 106 111. (Pubitemid 30061267)